Imunon, Inc. – NASDAQ:CLSN

Imunon stock price today

$1.96
Financial Health
0
1
2
3
4
5
6
7
8
9

Imunon stock price monthly change

-13.65%
month

Imunon stock price quarterly change

+5.95%
quarter

Imunon stock price yearly change

+104.17%
year

Imunon key metrics

Market Cap
14.47M
Enterprise value
N/A
P/E
-0.49
EV/Sales
-17.84
EV/EBITDA
0.32
Price/Sales
36.24
Price/Book
0.28
PEG ratio
N/A
EPS
-2.02
Revenue
N/A
EBITDA
-19.07M
Income
-18.85M
Revenue Q/Q
N/A
Revenue Y/Y
1780.19%
Profit margin
-6973.1%
Oper. margin
-5966.05%
Gross margin
0%
EBIT margin
-5966.05%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Imunon stock price history

Imunon stock forecast

Imunon financial statements

Imunon, Inc. (NASDAQ:CLSN): Profit margin
Jun 2023 0 -5.55M
Sep 2023 0 -3.47M
Dec 2023 7.05M -4.88M -69.33%
Mar 2024 0 -4.92M
Imunon, Inc. (NASDAQ:CLSN): Earnings per share (EPS)
2022-05-16 -0.99 -1.82
2022-08-15 -1.12 -0.87
Imunon, Inc. (NASDAQ:CLSN): Debt to assets
Jun 2023 28721694 7.20M 25.09%
Sep 2023 24654428 6.58M 26.7%
Dec 2023 21918069 8.53M 38.92%
Mar 2024 14324768 5.82M 40.66%
Imunon, Inc. (NASDAQ:CLSN): Cash Flow
Jun 2023 -6.69M 3.12M -6.22M
Sep 2023 -4.47M 10.66M 78.26K
Dec 2023 -3.77M -3.30M 30.24K
Mar 2024 -5.87M 2.38M 0

Imunon alternative data

Imunon, Inc. (NASDAQ:CLSN): Employee count
Aug 2023 29
Sep 2023 29
Oct 2023 29
Nov 2023 29
Dec 2023 29
Jan 2024 29
Feb 2024 29
Mar 2024 29
Apr 2024 29
May 2024 29
Jun 2024 29
Jul 2024 29

Imunon other data

78.60% +33.61%
of CLSN is owned by hedge funds
918.35K +392.72K
shares is hold by hedge funds

Imunon, Inc. (NASDAQ:CLSN): Insider trades (number of shares)
Period Buy Sel
May 2021 5000 0
Oct 2021 20000 0
Mar 2022 2000 0
Apr 2022 9000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
TARDUGNO MICHAEL H director, officer.. Celsion Corporation Common Stock 4,000 $3.53 $14,128
Purchase
TARDUGNO MICHAEL H director, officer.. Celsion Corporation Common Stock 4,000 $3.53 $14,128
Purchase
FRITZ FREDERICK J. director
Celsion Corporation Common Stock 5,000 $4.05 $20,250
Purchase
FRITZ FREDERICK J. director
Celsion Corporation Common Stock 2,000 $4.69 $9,372
Purchase
FRITZ FREDERICK J. director
Celsion Corporation Common Stock 20,000 $0.88 $17,600
Purchase
BRAUN DONALD P director
Celsion Corporation Common Stock 5,000 $1.07 $5,350
Purchase
MARTINEZ ALBERTO R JR director
Celsion Corporation Common Stock 5,000 $0.9 $4,500
Purchase
MARTINEZ ALBERTO R JR director
Celsion Corporation Common Stock 6,000 $1.42 $8,520
Purchase
FRITZ FREDERICK J. director
Celsion Corporation Common Stock 10,000 $1.39 $13,880
Purchase
MARTINEZ ALBERTO R JR director
Celsion Corporation Common Stock 4,000 $1.61 $6,440
Insider Compensation
Mr. Michael H. Tardugno (1951) Executive Chairman, Pres & Chief Executive Officer $1,000,000
Dr. Nicholas Borys (1959) Executive Vice President & Chief Medical Officer $582,240
Mr. Jeffrey W. Church CPA, CPA (1957) Chief Financial Officer, Executive Vice President & Corporation Sec.
$522,620
Dr. Khursheed Anwer M.B.A., Ph.D. (1960) Executive Vice President & Chief Scientific Officer
$484,750
Monday, 19 September 2022
globenewswire.com
Thursday, 15 September 2022
globenewswire.com
Monday, 12 September 2022
GlobeNewsWire
Wednesday, 7 September 2022
GlobeNewsWire
Monday, 15 August 2022
Seeking Alpha
Monday, 8 August 2022
GlobeNewsWire
Monday, 16 May 2022
Seeking Alpha
Monday, 9 May 2022
GlobeNewsWire
Wednesday, 6 April 2022
Benzinga
GlobeNewsWire
Tuesday, 5 April 2022
Benzinga
Thursday, 31 March 2022
Seeking Alpha
Thursday, 24 March 2022
GlobeNewsWire
Tuesday, 1 March 2022
Pulse2
Monday, 29 November 2021
GlobeNewsWire
Monday, 15 November 2021
Seeking Alpha
Tuesday, 9 November 2021
GlobeNewsWire
Friday, 15 October 2021
GlobeNewsWire
Tuesday, 12 October 2021
Pulse2
GlobeNewsWire
Monday, 11 October 2021
GlobeNewsWire
Friday, 17 September 2021
GlobeNewsWire
Friday, 10 September 2021
PennyStocks
Friday, 3 September 2021
Zacks Investment Research
Thursday, 19 August 2021
PennyStocks
  • What's the price of Imunon stock today?

    One share of Imunon stock can currently be purchased for approximately $1.96.

  • When is Imunon's next earnings date?

    Unfortunately, Imunon's (CLSN) next earnings date is currently unknown.

  • Does Imunon pay dividends?

    No, Imunon does not pay dividends.

  • How much money does Imunon make?

    Imunon has a market capitalization of 14.47M. Imunon made a loss 19.51M US dollars in net income (profit) last year or -$0.87 on an earnings per share basis.

  • What is Imunon's stock symbol?

    Imunon, Inc. is traded on the NASDAQ under the ticker symbol "CLSN".

  • What is Imunon's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Imunon?

    Shares of Imunon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Imunon's key executives?

    Imunon's management team includes the following people:

    • Mr. Michael H. Tardugno Executive Chairman, Pres & Chief Executive Officer(age: 74, pay: $1,000,000)
    • Dr. Nicholas Borys Executive Vice President & Chief Medical Officer(age: 66, pay: $582,240)
    • Mr. Jeffrey W. Church CPA, CPA Chief Financial Officer, Executive Vice President & Corporation Sec.(age: 68, pay: $522,620)
    • Dr. Khursheed Anwer M.B.A., Ph.D. Executive Vice President & Chief Scientific Officer(age: 65, pay: $484,750)
  • How many employees does Imunon have?

    As Jul 2024, Imunon employs 29 workers.

  • When Imunon went public?

    Imunon, Inc. is publicly traded company for more then 31 years since IPO on 27 Oct 1993.

  • What is Imunon's official website?

    The official website for Imunon is celsion.com.

  • Where are Imunon's headquarters?

    Imunon is headquartered at 997 Lenox Dr Ste 100, Lawrence Township, NEW JERSEY.

  • How can i contact Imunon?

    Imunon's mailing address is 997 Lenox Dr Ste 100, Lawrence Township, NEW JERSEY and company can be reached via phone at +1 609 896 9100.

Imunon company profile:

Imunon, Inc.

celsion.com
Exchange:

NASDAQ

Full time employees:

29

Industry:

Biotechnology

Sector:

Healthcare

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

997 Lenox Dr Ste 100
Lawrence Township, NEW JERSEY 08648

CIK: 0000749647
ISIN: US15117N6022
CUSIP: 15117N602